🇺🇸 FDA
Pipeline program

Rilonacept

IL1T-GA-0815

Phase 3 mab completed

Quick answer

Rilonacept for Gout is a Phase 3 program (mab) at Regeneron UK Limited with 3 ClinicalTrials.gov record(s).

Program details

Company
Regeneron UK Limited
Indication
Gout
Phase
Phase 3
Modality
mab
Status
completed

Clinical trials